Clofazimine Is a Safe and Effective Alternative for Rifampicin in Mycobacterium avium Complex Pulmonary Disease Treatment-Reference-Cited by-同舟云学术

Clofazimine Is a Safe and Effective Alternative for Rifampicin in Mycobacterium avium Complex Pulmonary Disease Treatment

Published:2023-11 Issue: Volume: Page:
ISSN:0012-3692
Container-title:CHEST
language:en
Short-container-title:CHEST

Author:

Zweijpfenning Sanne M.H.,Aarnoutse Rob,Boeree Martin J.,Magis-Escurra Cecile,Stemkens Ralf^ORCID,Geurts Bram^ORCID,van Ingen Jakko^ORCID,Hoefsloot Wouter^ORCID

Funder

Novartis

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference25 articles.

1. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline;Daley;Eur Respir J,2020

2. Drug treatment of pulmonary nontuberculous mycobacterial disease in HIV-negative patients: the evidence;van Ingen;Expert Rev Anti Infect Ther,2013

3. Non-tuberculous mycobacterial pulmonary disease;Cowman;Eur Respir J,2019

4. Treatment and outcome of non-tuberculous mycobacterial pulmonary disease in a predominantly fibro-cavitary disease cohort;Zweijpfenning;Respir Med,2017

5. Management of drug toxicity in Mycobacterium avium complex pulmonary disease: an expert panel survey;van Ingen;Clin Infect Dis,2021

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug–drug interactions in the management of non-tuberculous mycobacterial infections;Frontiers in Microbiology;2024-09-05

2. Clofazimine serum concentration and safety/efficacy in nontuberculous mycobacterial pulmonary disease treatment;Respiratory Medicine;2024-09

3. “How do I manage disseminated Mycobacterium avium complex (MAC) disease in people with HIV?”;Clinical Microbiology and Infection;2024-08

4. Low azithromycin maximal concentrations in patients concomitantly taking rifampicin: time to move away from rifampicin in the treatment of non-tuberculous mycobacteria?;Antimicrobial Agents and Chemotherapy;2024-07-09

5. Growing from common ground: nontuberculous mycobacteria and bronchiectasis;European Respiratory Review;2024-07